|View printer-friendly version|
WILMINGTON, Mass.--(BW HealthWire)--June 22, 2001--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to file a registration statement with the Securities and Exchange Commission on June 25, 2001 for a proposed underwritten offering of 8,000,000 shares of its common stock, plus an additional 1,200,000 shares to cover over-allotments if the underwriters exercise the over-allotment option. The Company will sell 2,000,000 shares and selling shareholders will sell the remaining 6,000,000 shares and the 1,200,000 over-allotment shares, if any.
This release is not an offer to sell or a solicitation of an offer to buy any of these securities.
|CONTACT:||Charles River Laboratories International, Inc.|